Fact CheckerSign in

NCT02061787Recruiting

the Application of Cardiopulmonary Exercise Testing in Assessment Outcome of Patients With Pulmonary Hypertension

Source: ClinicalTrials.gov · Last updated 19 Sept 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

cardiopulmonary exercise test evaluate patients with pulmonary hypertension before and after medical or balloon pulmonary angioplasty treatment

Status (registry)
Recruiting
Study type
Observational
Enrollment
4000 (estimated)
First submitted
11 Feb 2014
Start date
Sept 2010
Primary completion date
8 Sept 2030
Lead sponsor
Chinese Pulmonary Vascular Disease Research Group
NCT number
NCT02061787

What you commit to

  • Study type: Observational
  • Planned participants: 4000
  • From Sept 2010 to the primary completion date, 8 Sept 2030
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • unable to accomplish cardiopulmonary exercise testing due to neuromuscular disorders;
  • pulmonary hypertension due to hypoxia;
  • pulmonary hypertension due to left heart diseases.

Other

  • massive hemoptysis;
  • recent recurrent syncope;

Who the study is looking for

  • pulmonary arterial hypertension;( WHO1)
  • chronic thromboembolic pulmonary hypertension;
  • pulmonary arterial hypertension due to other cause;

Age in the registry: 5 years to 100 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
center of pulmonary vascular disease, Fuwai hospital
Coordinator of this site? Confirm its status
BeijingChinaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.